Encore Pharma

Treatments of ophthalmic diseases

Website
Encore Pharmaceuticals is a development of new clinical applications for what were considered to be “old” drugs.
Domain

Topical Ophthamology

Partnered

Seed, Series A, Series B

Current Status

Acquired by Novartis

Investors

Tom Mather

Leadership

Bill Burns, CEO

HQ

Forth Worth, TX

In the News

View all